184 related articles for article (PubMed ID: 36733239)
1. The Advances in Chitosan-based Drug Delivery Systems for Colorectal Cancer: A Narrative Review.
Ali DS; Othman HO; Anwer ET
Curr Pharm Biotechnol; 2023; 24(12):1554-1559. PubMed ID: 36733239
[TBL] [Abstract][Full Text] [Related]
2. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
[TBL] [Abstract][Full Text] [Related]
3. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
Kamath PR; Sunil D
Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
[TBL] [Abstract][Full Text] [Related]
4. Prospects and challenges of anticancer agents' delivery via chitosan-based drug carriers to combat breast cancer: a review.
Wang G; Li R; Parseh B; Du G
Carbohydr Polym; 2021 Sep; 268():118192. PubMed ID: 34127212
[TBL] [Abstract][Full Text] [Related]
5. Cromolyn chitosan nanoparticles as a novel protective approach for colorectal cancer.
Motawi TK; El-Maraghy SA; ElMeshad AN; Nady OM; Hammam OA
Chem Biol Interact; 2017 Sep; 275():1-12. PubMed ID: 28732690
[TBL] [Abstract][Full Text] [Related]
6. Advances in chitosan-based nanoparticles for oncotherapy.
Zhang E; Xing R; Liu S; Qin Y; Li K; Li P
Carbohydr Polym; 2019 Oct; 222():115004. PubMed ID: 31320066
[TBL] [Abstract][Full Text] [Related]
7. Chitosan and Wnt/β-catenin Signaling Pathways in Different Cancers.
Eslahi M; Sadoughi F; Asemi Z; Yousefi B; Mansournia MA; Hallajzadeh J
Comb Chem High Throughput Screen; 2021; 24(9):1323-1331. PubMed ID: 33081676
[TBL] [Abstract][Full Text] [Related]
8. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD
Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
[TBL] [Abstract][Full Text] [Related]
9. ROS-Responsive Chitosan Coated Magnetic Iron Oxide Nanoparticles as Potential Vehicles for Targeted Drug Delivery in Cancer Therapy.
Ayyanaar S; Balachandran C; Bhaskar RC; Kesavan MP; Aoki S; Raja RP; Rajesh J; Webster TJ; Rajagopal G
Int J Nanomedicine; 2020; 15():3333-3346. PubMed ID: 32494133
[TBL] [Abstract][Full Text] [Related]
10. The effects of chitosan-based materials on glioma: Recent advances in its applications for diagnosis and treatment.
Eslahi M; Dana PM; Asemi Z; Hallajzadeh J; Mansournia MA; Yousefi B
Int J Biol Macromol; 2021 Jan; 168():124-129. PubMed ID: 33275978
[TBL] [Abstract][Full Text] [Related]
11. Micelles as potential drug delivery systems for colorectal cancer treatment.
Fatfat Z; Fatfat M; Gali-Muhtasib H
World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
[TBL] [Abstract][Full Text] [Related]
12. Development of enteric-coated, biphasic chitosan/HPMC microcapsules for colon-targeted delivery of anticancer drug-loaded nanoparticles.
Ma Y; Thurecht KJ; Coombes AGA
Int J Pharm; 2021 Sep; 607():121026. PubMed ID: 34418474
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable disulfide crosslinked chitosan/stearic acid nanoparticles for dual drug delivery for colorectal cancer.
Sood A; Gupta A; Bharadwaj R; Ranganath P; Silverman N; Agrawal G
Carbohydr Polym; 2022 Oct; 294():119833. PubMed ID: 35868778
[TBL] [Abstract][Full Text] [Related]
14. Research Progress of Chitosan-based Multifunctional Nanoparticles in Cancer Targeted Therapy.
Lai C; Lin S; Liu W; Jin Y
Curr Med Chem; 2024; 31(21):3074-3092. PubMed ID: 37062062
[TBL] [Abstract][Full Text] [Related]
15. Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer.
Abdellatif AAH; Alshubrumi AS; Younis MA
AAPS PharmSciTech; 2024 Jan; 25(1):23. PubMed ID: 38267656
[TBL] [Abstract][Full Text] [Related]
16. Targeted nanoparticles for colorectal cancer.
Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
[TBL] [Abstract][Full Text] [Related]
17. Development of chitosan/halloysite/graphitic‑carbon nitride nanovehicle for targeted delivery of quercetin to enhance its limitation in cancer therapy: An in vitro cytotoxicity against MCF-7 cells.
Sabzini M; Pourmadadi M; Yazdian F; Khadiv-Parsi P; Rashedi H
Int J Biol Macromol; 2023 Jan; 226():159-171. PubMed ID: 36435458
[TBL] [Abstract][Full Text] [Related]
18. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery.
Samprasit W; Opanasopit P; Chamsai B
Pharm Dev Technol; 2021 Mar; 26(3):362-372. PubMed ID: 33423571
[TBL] [Abstract][Full Text] [Related]
19. Ionically Cross-Linked Chitosan Nanoparticles for Sustained Delivery of Docetaxel: Fabrication, Post-Formulation and Acute Oral Toxicity Evaluation.
Mahmood MA; Madni A; Rehman M; Rahim MA; Jabar A
Int J Nanomedicine; 2019; 14():10035-10046. PubMed ID: 31908458
[TBL] [Abstract][Full Text] [Related]
20. The potential role of chitosan-based nanoparticles as drug delivery systems in pancreatic cancer.
Sadoughi F; Mansournia MA; Mirhashemi SM
IUBMB Life; 2020 May; 72(5):872-883. PubMed ID: 32057169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
